253 related articles for article (PubMed ID: 11719215)
41. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
Little JL; Serzhanova V; Izumchenko E; Egleston BL; Parise E; Klein-Szanto AJ; Loudon G; Shubina M; Seo S; Kurokawa M; Ochs MF; Golemis EA
Oncogene; 2014 Jan; 33(4):411-20. PubMed ID: 23318423
[TBL] [Abstract][Full Text] [Related]
42. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
43. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
44. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
45. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM
Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322
[TBL] [Abstract][Full Text] [Related]
46. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.
Weaver ZA; McCormack SJ; Liyanage M; du Manoir S; Coleman A; Schröck E; Dickson RB; Ried T
Genes Chromosomes Cancer; 1999 Jul; 25(3):251-60. PubMed ID: 10379871
[TBL] [Abstract][Full Text] [Related]
47. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
48. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y
Technol Cancer Res Treat; 2006 Dec; 5(6):565-71. PubMed ID: 17121432
[TBL] [Abstract][Full Text] [Related]
49. Targeting FACT complex suppresses mammary tumorigenesis in Her2/neu transgenic mice.
Koman IE; Commane M; Paszkiewicz G; Hoonjan B; Pal S; Safina A; Toshkov I; Purmal AA; Wang D; Liu S; Morrison C; Gudkov AV; Gurova KV
Cancer Prev Res (Phila); 2012 Aug; 5(8):1025-35. PubMed ID: 22689915
[TBL] [Abstract][Full Text] [Related]
50. Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice.
Wong PS; Matsumura F
BMC Cancer; 2007 Jul; 7():130. PubMed ID: 17640349
[TBL] [Abstract][Full Text] [Related]
51. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
[TBL] [Abstract][Full Text] [Related]
52. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors.
Galang CK; Muller WJ; Foos G; Oshima RG; Hauser CA
J Biol Chem; 2004 Mar; 279(12):11281-92. PubMed ID: 14662758
[TBL] [Abstract][Full Text] [Related]
53. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
[TBL] [Abstract][Full Text] [Related]
54. [Searching for retroviral sequences related to human breast cancer].
Pogo BG; Holland JF; Wang Y; Melana SM; Pelisson I; Liu B; Go V; Bleiweiss I
Medicina (B Aires); 1997; 57 Suppl 2():75-80. PubMed ID: 9567345
[TBL] [Abstract][Full Text] [Related]
55. The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis.
de Launoit Y; Chotteau-Lelievre A; Beaudoin C; Coutte L; Netzer S; Brenner C; Huvent I; Baert JL
Adv Exp Med Biol; 2000; 480():107-16. PubMed ID: 10959416
[TBL] [Abstract][Full Text] [Related]
56. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
57. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
58. Role for ETS domain transcription factors Pea3/Erm in mouse lung development.
Liu Y; Jiang H; Crawford HC; Hogan BL
Dev Biol; 2003 Sep; 261(1):10-24. PubMed ID: 12941618
[TBL] [Abstract][Full Text] [Related]
59. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
[TBL] [Abstract][Full Text] [Related]
60. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation.
Bojović BB; Hassell JA
DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
